Aprea Therapeutics, Inc.
APRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781983
No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Aprea Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +4 vs. Q4 2023
- Shares held
- 1.63M
- +698.5K (+75.4%) vs. Q4 2023
- Total value
- $10.8M
- +$6.41M (+147.2%) vs. Q4 2023
- New holders
- 7
- 6 more added
- Sold out
- 3
- 3 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $1.90M |
| Q1 2026 | 22 | $1.71M |
| Q4 2025 | 22 | $1.45M |
| Q3 2025 | 23 | $2.39M |
| Q2 2025 | 23 | $3.07M |
| Q1 2025 | 26 | $3.78M |
| Q4 2024 | 26 | $6.83M |
| Q3 2024 | 22 | $5.50M |
| Q2 2024 | 28 | $8.48M |
| Q1 2024 | 24 | $10.8M |
| Q4 2023 | 20 | $4.36M |
| Q3 2023 | 21 | $3.66M |
| Q2 2023 | 19 | $2.78M |
| Q1 2023 | 18 | $3.77M |
| Q4 2022 | 25 | $521.3K |
| Q3 2022 | 27 | $1.11M |
| Q2 2022 | 34 | $1.52M |
| Q1 2022 | 40 | $4.50M |
| Q4 2021 | 41 | $10.4M |
| Q3 2021 | 39 | $25.6M |
| Q2 2021 | 50 | $31.9M |
| Q1 2021 | 67 | $45.4M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Aprea Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 539,300 | $3.50M | 1.69% | +190,000+54.4% | Added |
| Sio Capital Management, LLC | 276,603 | $1.85M | 0.64% | −3,397−1.2% | Reduced |
| Sphera Funds Management Ltd. | 270,000 | $1.81M | 0.29% | +270,000 | New |
| Nantahala Capital Management, LLC | 205,760 | $1.38M | 0.13% | +205,760 | New |
| DAFNA Capital Management LLC | 137,174 | $917.7K | 0.21% | +137,174 | New |
| Vanguard Group Inc | 115,978 | $775.9K | 0.00% | +81,290+234.3% | Added |
| Morgan Stanley | 26,818 | $179.4K | 0.00% | +9,600+55.8% | Added |
| Geode Capital Management, LLC | 20,221 | $135.3K | 0.00% | +2,748+15.7% | Added |
| HighTower Advisors, LLC | 13,864 | $93.0K | 0.00% | +13,864 | New |
| BlackRock Inc. | 8,504 | $56.9K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,570 | $17.0K | 0.00% | −41,455−94.2% | Reduced |
| Group One Trading, L.P. | 2,160 | $14.4K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,566 | $10.5K | 0.00% | −1,685−51.8% | Reduced |
| Tower Research Capital LLC (TRC) | 1,126 | $7.53K | 0.00% | +578+105.5% | Added |
| The PNC Financial Services Group, Inc. | 1,000 | $6.69K | 0.00% | 00.0% | Unchanged |
| NBC Securities, Inc. | 899 | $6.00K | 0.00% | +899 | New |
| MB, Levis & Associates, LLC | 806 | $5.39K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 300 | $2.01K | 0.00% | +100+50.0% | Added |
| Wells Fargo & Company | 272 | $1.82K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 161 | $1.08K | 0.00% | +161 | New |
| WealthCollab, LLC | 158 | $1.06K | 0.00% | 00.0% | Unchanged |
| Princeton Global Asset Management LLC | 100 | $669 | 0.00% | 00.0% | Unchanged |
| Old Point Trust & Financial Services N A | 50 | $335 | 0.00% | +50 | New |
| UBS Group AG | 3 | $20 | 0.00% | 00.0% | Unchanged |
| Worth Venture Partners, LLC | 0 | $0 | 0.00% | −87,169−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −80,000−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −5−100.0% | Sold out |